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Abstract
Thyroid hormone (TH) is essential for brain development. While disruption of TH signaling
by environmental chemicals has been discussed as a mechanism of developmental neuro-
toxicity (DNT) for more than a decade, there remains a paucity of information linking specific
TH disrupting chemicals to adverse neurodevelopmental outcomes. This data gap reflects,
in part, the fact that the molecular machinery of TH signaling is complex and varies accord-
ing to cell type and developmental time. Thus, establishing a baseline of the ontogenetic
profile of expression of TH signaling molecules in relevant cell types is critical for developing
in vitro and alternative systems-based models for screening TH disrupting chemicals for
DNT. Here, we characterize the transcriptomic profile of molecules critical to TH signaling
across three species–human, rat, and zebrafish–in vitro and in vivo across different stages
of neurodevelopment. Our data indicate that while cultured human and rat neural progenitor
cells, primary cultures of rat cortical cells, and larval zebrafish all express a fairly compre-
hensive transcriptome of TH signaling molecules, the spatiotemporal expression profiles as
well as the responses to TH vary across species and developmental stages. The data pre-
sented here provides a roadmap for identifying appropriate in vitro and in simpler systems-
based models for mechanistic studies and screening of chemicals that alter neurodevelop-
ment via interference with TH action.
Introduction
The potential for developmental exposure to environmental chemicals to cause neurodevelop-
mental defects by disrupting thyroid hormone (TH) activity has been under discussion for
more than a decade [1–3]. This discussion is driven in large part by clinical evidence demon-
strating that the thyroid hormones L-3,5,3’,5’-Tetraiodothyronine (T4) and 3,3’,5-triiodo-L-
thyronine (T3) are essential for proper brain development. Children with severe prenatal TH
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deficiency exhibit symptoms including mental retardation, spasticity, deaf-mutism and hear-
ing loss [4–6]. Less severe prenatal TH deficiency is associated with delayed mental and motor
development, and lower IQ [7,8]. Conditions known to interfere with normal neurodevelop-
ment by compromising TH action include iodine deficiency, maternal and fetal hypothyroid-
ism or hypothyroxinemia, and mutations of the nuclear TH receptor (TR) alpha and beta as
well as of monocarboxylate 8 transporter (MCT8) gene SLC16A2 [9].
In vitro approaches have identified numerous chemicals with TH activity, but an outstand-
ing question is whether hits in these screens are predictive of adverse neurodevelopmental out-
comes. The majority of cell systems used to screen chemical compounds for effects on TH
signaling are largely comprised of non-neural cells that overexpress molecules relevant for TH
synthesis or direct TH genomic effects, i.e. the thyroid hormone receptor (TR) [10–13]. The
former do not address potential effects at the level of the target cell, which may be a critical
deficiency for developmental neurotoxicity (DNT) in light of experimental evidence demon-
strating that chemical-induced decreases in circulating TH do not necessarily translate to
decreased TH activity in the developing brain [14]. While the use of non-neural cells that over-
express distinct TR isoforms have the potential to detect actions of chemical compounds on
cellular TR signaling, these models do not account for the known diversity of TH actions
across different cell types that vary according to the role of TR and its binding partners includ-
ing co-activators and co-repressors in cellular development and physiology [15]. Moreover,
the presence and/or induction of deiodinases in target cells is a critical determinant of cellular
TH action [16]. Thus, there is an urgent need to develop higher throughput models to screen
chemical compounds for effects on TH signaling in developing brain cells. This will require
cell systems that: (i) consist of cell types relevant for TH action in neurodevelopment, i.e. neu-
rons and glia cells; (ii) are well-characterized with respect to TH actions and signaling path-
ways; (iii) represent defined developmental time windows with relation to TH function in
vivo; and (iv) are representative of relevant TH biology.
Developing models to screen chemicals for their ability to directly interfere with TH action
in the developing brain has been challenging, in part because the expression profile of key mol-
ecules involved in regulating TH activity in target cells (Fig 1) across different periods of brain
development in different species is largely unknown. Therefore, the goal of this study was to
address this data gap by comparing the transcriptomic profile of key TH signaling molecules,
identified in Table 1, in various rat versus human in vitro models, as well as zebrafish larvae
models. Because TH effects differ across developmental stages [17,18], and different in vitro
models recapitulate different neurodevelopmental processes, we employed multiple in vitro
model systems that captured differing periods of neurodevelopment. Fig 2 illustrates that the
different models appear phenotypically as expected, i.e. containing neural cells of the neuronal
and glial lineage at different maturation stages. One model we used was human neural progen-
itor cells (hNPC) derived from gestational week (GW) 16–18 brain tissue. In human fetal
brains, TR transcripts are measurable as early as GW 10, and their concentration increases
10-fold until GW 16–18, which represents a 500-fold absolute gain in TR expression due to the
increase in brain weight during that period [19]. The timing of brain development differs
between species [20], but using an on-line tool for matching neurodevelopmental stages across
species (www.translatingtime.org), we determined that human GW 16–18 corresponds
approximately to postnatal day (PND) 0–1 in the rat. In the developing rat brain, in vivo T3
binding to TR is detectable at embryonic day E13.5–14, and reaches a maximum on PND 6
[21]. As previously described [22], these data regarding the ontogenesis of the TH signaling
molecules in the human and rat, and the timing of analogous neurodevelopmental processes
between these two species, provided the rationale for our decision to compare mRNA levels of
critical TH signaling molecules in developing human and rat NPC from GW 16–18 and PND
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Fig 1. Schematic of the canonical TH signaling pathway. The canonical mechanism of TH action involves uptake of L-thyroxine (T4) or triiodothyronine
(T3) into the cell by TH transporters, including the monocarboxylate transporter 8 (MCT8), L-type amino acid transporters (LAT) 1 and 2, and organic anion
transporter protein (OATP) 1c1. Cellular deiodinase 2 (DIO2) converts T4 to T3, which has a higher binding affinity to the TH receptors (THR) α and β. DIO3
converts T4 to reverse T3 (rT3) and T3 to T2. The general model of TH regulation of gene transcription involves TH receptors (TRs; genes THR) that reside in
the nucleus bound to DNA as homo- or possibly heterodimers with the retinoid X receptor (RXR) complexed with among others nuclear co-repressor 1
(NCOR1). Upon ligand binding, the TR-RXR complex releases NCOR1 and recruits activator proteins to initiate transcription of target genes, which include
DIO3, kruppel-like factor 9 (), myelin basic protein (MBP), myelin-associated oligodendrocyte basic protein (MOBP), and hairless (HR) [reviewed by 26]).
https://doi.org/10.1371/journal.pone.0221230.g001
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1, respectively. NPC cultures capture early stages of neurodevelopment, such as neurogenesis,
neuronal and glial cell differentiation and neural cell migration (Fig 2). To examine the expres-
sion of TH signaling molecules at later stages of neurodevelopment, including axonal and den-
dritic outgrowth, and synaptogenesis, we performed transcriptomic analyses of rat primary
neuron-glia co-cultures derived from PND 1 rat cortex that were cultured for up to 21 days in
vitro (DIV) [23]. Finally, we also examined the ontogenetic profile of these transcripts in zebra-
fish larvae since this model has been proposed as an alternative organism for screening the
DNT potential of TH active chemical compounds [24,25]. Moreover, zebrafish offer the poten-
tial for future studies to integrate molecular effects of TH disruption with physiological and
behavioral outcomes.
Collectively, the findings from this study indicate that while all of these models express a
fairly comprehensive transcriptome of TH signaling molecules, their expression does not cor-
relate with functionality of TH signaling studied by target gene expression responses to TH.
Materials and methods
Animals
Studies involving primary rat cortical cell cultures and transcriptomic analyses of rat cortical
tissues performed at the University of California-Davis (UC Davis) were approved by the UC
Davis Institutional Animal Care and Use Committee (Public Health Services (PHS)/National
Institutes of Health (NIH) Assurance #A3433-01; protocol 20541). Studies involving rat neuro-
spheres and transcriptomic analyses of whole rat brains performed at the IUF in Du¨sseldorf
were approved by the State Agency for Nature, Environment and Consumer Protection North
Rhine-Westphalia (LANUV) in Germany (license number 84–02.05.40.14.140). Timed preg-
nant Sprague Dawley rats were purchased by UC Davis investigators from Charles River Labo-
ratories (Hollister, CA, USA) whereas timed pregnant Wistar rats were purchased by IUF
investigators from Charles River Laboratories (Sulzfeld, Germany). Pregnant females were
housed individually in plastic cages with corn cob bedding in a temperature controlled room
(22 ± 2 oC) on a 12 hr light-dark cycle. Food and water were provided ad libitum to the dams.
Table 1. Components of the TH signaling system in different species.
Gene name Gene (isoform) symbol Function
human rat zebrafish
L-type amino acid transporter 1 LAT1 (SLC7A5) Lat1 lat1 TH transporter
L-type amino acid transporter 2 LAT2 Lat2 lat2 TH transporter
Monocarboxylate transporter 8 MCT8 (SLC16A2) Mct8 mct8 TH transporter
Organic anion transporting protein 1C1 OATP1C1 Oatp1c1 oatp1c1 TH transporter
Deiodinase 2 DIO2 Dio2 dio2 TH activating enzyme
Deiodinase 3 DIO3 Dio3 dio3a dio3b TH inactivating enzyme
Thyroid hormone receptor alpha THRA1 THRA2 Thra1 Thra2 thraa thrab TH receptor
Thyroid hormone receptor beta THRB Thrb thrb TH receptor
Nuclear Receptor Corepressor 1 NCOR1 Ncor1 ncor1 Corepressor of TH receptor
Krueppel-like factor 9 KLF9 Klf9 klf9 TH target gene
Myelin basic protein MBP not studied� mbpa TH target gene
Myelin-Associated Oligodendrocyte Basic Protein not studied� Mobp not studied� TH target gene
Hairless HR Hhr hr TH target gene
�respective genes were not studied in the indicated species.
https://doi.org/10.1371/journal.pone.0221230.t001
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Studies involving zebrafish were performed at UC Davis in accordance with protocols
approved by the UC Davis Institutional Animal Care and Use Committee (PHS/NIH Assur-
ance #A3433-01; protocols 17645 and 19391). Adult wildtype zebrafish (5D) were originally
obtained from the Sinnhuber Aquatic Research Laboratory (SARL) at Oregon State University
(Corvallis, OR, U.S.) and subsequent generations were raised at UC Davis. Adult zebrafish
were maintained in a 14 h light (~850 lux)/10 h dark photoperiod (Harper and Lawrence,
2016) in water at a temperature of 28.5 ± 0.5 ˚C, pH of 7.2 ± 0.4, and conductivity of
700 ± 100 μS. Adult fish were fed twice daily with live Artemia nauplii (INVE Aquaculture,
Inc., Salt Lake City, UT, USA) and a mixture of the following commercial flake foods: Zeigler
Fig 2. Overview of in vitro and in vivo models used for expression analyses of TH signaling-related genes. Human and rat
neurospheres, primary rat cortical cell cultures and zebrafish larvae were used to study the expression of TH signaling components and
TH-responsive genes at multiple developmental stages. In human and rat neurospheres, gene expression was evaluated in proliferating
neurospheres and at days 3 and 5 of differentiation; in rat neuron-glia co-cultures at day in vitro (DIV) 2, 7 and 21, and in zebrafish
larvae at 0, 18, 24, 72 and 120 hours post fertilization (hpf). The fluorescent photomicrographs illustrate the differentiation of the human
and rat neurospheres and primary rat cortical cell cultures at these specific developmental stages; the transmission images, the
morphology of the neurosphere cultures and zebrafish at different stages of development. The markers used for immunocytochemical
analyses include βIII-tubulin (neurons), glial fibrillary acidic protein (GFAP; astrocytes), O4 (oligodendrocytes), microtubule-associated
protein 2 (MAP2B; soma and dendrites of neurons), tau (axons of neurons), and Hoechst (cell nuclei). Scale bars are 200 μm
(proliferating neuropheres), 150 μm (transmission images of differentiating neurospheres) or 50 μm (fluorescent photomicrographs).
https://doi.org/10.1371/journal.pone.0221230.g002
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Zebrafish Granule (Ziegler Bros, Inc. Gardners, PA, USA), Spirulina flake (Zeigler Bros, Inc.),
Cyclopeeze (Argent Aquaculture, Redmond, WA, USA), and Golden Pearl (Brine Shrimp
Direct, Ogden, UT, USA). Adult zebrafish were spawned naturally in groups of 8–10 fish;
embryos were collected and staged following fertilization as previously described (Kimmel
et al., 1995).
Zebrafish embryo sampling
Zebrafish embryos and larvae were raised in embryo medium (15 mM NaCl, 0.5 mM KCl, 1.0
mM MgSO4, 150 μM KH2PO4, 50 μM Na2HPO4, 1.0 mM CaCl2, 0.7 mM NaHCO3) in 30 mm
tissue culture dishes placed in a 28.5 ˚C incubator with a 14 h light/10 h dark photoperiod.
Zebrafish embryos were collected for transcriptomic analyses at 18, 24, 72, and 120 hours post
fertilization (hpf). Groups of 30 embryos were pooled and stored in 1 mL RNAlater (Thermo
Fisher Scientific) at 4 ˚C for 24 h and then at -20 ˚C until RNA was extracted. Three biological
replicates were collected at each time point with embryos spawned from different adult pairs.
In order to determine the change in expression induced by TH exposure, zebrafish embryos
were treated with embryo medium supplemented with T4 (Sigma) or T3 (Sigma) at 10, 30, or
100 nM in 6-well tissue culture plates (BD Falcon, Corning) beginning at 6 hpf. Twenty
embryos were treated in each well and pooled at the time of sample collection. Embryos were
collected in RNAlater (ThermoFisher Scientific), stored at 4 ˚C for 24 h and then at -20 ˚C
until RNA was extracted.
Cell culture
Rat cortical cell cultures (rCCC). Primary cultures of dissociated rat cortical neuron-glia
co-cultures were prepared and maintained as previously described [27]. Briefly, the neocorti-
ces of postnatal day (PND) 0–1 rat pups (males and females from the same litter were pooled)
were enzymatically dissociated and plated in 24-well tissue culture plates (Sarstedt) coated
with poly-L-lysine (molecular weight 300,000, Sigma). Cultures were maintained in NeuralQ
Basal Medium (MTI-Global Stem) supplemented with 2% GS21 Neural Supplement (MTI--
GlobalStem) and 2 mM Glutamax (Invitrogen) in the absence of serum. At DIV 4, cytosine-D-
arabinofuranoside (Sigma) was added to the culture medium at a final concentration of 5 μM.
Half of the medium in each well was replaced with fresh media weekly. In experiments where
TH concentration was altered, cultures were maintained in serum-free NeuralQ Medium sup-
plemented with 2 mM Glutamax, and a modified NS21 formulation [28] with 0.3, 3 or 30 nM
of T3 (Sigma) or T4 (Sigma); these TH concentrations were kept constant throughout the
experiment. In each experiment, 3 wells were set up per treatment condition. Each experiment
was performed 3 times using cultures derived from independent dissections.
Rat and human neural progenitor cell cultures. Normal human neural progenitor cells
(hNPC, gestational week 16–19) were purchased from Lonza Verviers SPRL. Experiments
with hNPC were approved by the Ethics Committee of the Heinrich-Heine-University, Du¨ssel-
dorf. Rat neural progenitor cells (rNPC) were prepared as described previously [29] from Wis-
tar Rats (Charles River, Sulzfeld, Germany) on postnatal day 1, which is a developmental stage
comparable to that of the hNPC [20]. Human and rat NPC were cultured in proliferation me-
dium consisting of 3:1 DMEM (Life Technologies) and Hams F12 (Life Technologies) media
supplemented with 2% B27 (Life Technologies), 20 ng/mL epidermal growth factor (EGF, Life
Technologies), 20 ng/mL human (hNPC) or 10 ng/mL rat (rNPC) recombinant human fibro-
blast growth factor (FGF, R&D Systems), and 1% penicillin and streptomycin (Pan-Biotech).
NPC were grown in a humidified incubator at 37 ˚C with 5% CO2 in suspension culture as
neurospheres and half of the medium was exchanged thrice a week. Neurospheres were
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mechanically passaged using a tissue chopper 2–3 days before starting proliferation or differ-
entiation experiments.
For proliferation experiments, 0.3 mm neurospheres were treated with proliferation medium
containing either vehicle (0.01% EtOH/HCl, which is a 1:1 mixture of 96% ethanol (EtOH) and 1
M HCl obtained from Carl Roth GmbH), T3 (Sigma) or T4 (Sigma) at 30 fM, 30 pM or 30 nM
for 3 d in 24-well plates (Sarstedt). In each experiment, triplicates of 15 neurospheres per well
were used per treatment condition. Differentiation was initiated by withdrawing growth factors
and plating 0.3 mm neurospheres onto poly-D-lysine (PDL)/laminin (Sigma-Aldrich) coated
24-well plates in 1 mL differentiation medium (3:1 Dulbecco´s modified Eagle medium and
Hams F12 supplemented with 1% N2 (Invitrogen GmBH) and 1% Penicillin/Streptomycin (Pan-
Biotech, Aidenbach, Germany) containing either vehicle (0.01% EtOH/HCl), T3 or T4. In each
experiment triplicates of 15 neurospheres per well were plated per treatment condition. Each
proliferation and differentiation experiment was performed at least three times independently.
RNA extraction and cDNA synthesis
Rat cortical cell cultures (rCCC) and rat cortical tissue. RNA was isolated from primary
rat cortical cell cultures on DIV 2, 7 and 21 using TRIzol Reagent (ThermoFisher Scientific)
according to the manufacturer’s protocol. RNA was isolated from rat cortical tissue (neocor-
tex) collected on PND 0/1 and 7 from euthanized rat pups. Neocortices from male and female
pups of the same litter were pooled, and samples were collected from 3 independent litters
(n = 3 biological replicates for each time point). Harvested tissues were placed in RNAlater
solution (Ambion/ThermoFisher Scientific) overnight at 4 oC and stored at -20 oC until fur-
ther processed. Cortical tissues were thawed on ice, and then homogenized in TRIzol Reagent.
RNA was isolated from homogenates according to the manufacturer’s protocol. Following
extraction, RNA concentration was determined using a NanoDrop ND-1000 spectrophotome-
ter (NanoDrop Technologies Inc.). Nucleic acid purity was determined based on the ratio of
absorbance at 260 nm to 280 nm (A260/A280 of 1.8–2.2 was considered acceptable), and the
absence of genomic DNA contamination was determined by visualization on an agarose gel
stained by SYBR Green nucleic acid gel stain (ThermoFisher Scientific). RNA was reverse tran-
scribed at a concentration of 1 μg of RNA per 20 μL reaction, using the Superscript VILO
cDNA synthesis kit (Invitrogen) according to the manufacturer’s instructions.
Zebrafish. To extract RNA, zebrafish were removed from RNAlater and homogenized in
350 μL of RLT buffer in the Qiagen RNeasy kit (Qiagen) with 1 mm glass beads using the Bullet
Blender (Next Advance, Troy, NY). Homogenates were transferred to 1.5 mL Eppendorf tubes
and spun in a tabletop centrifuge at maximum speed (21000 x g) for 3 min. The supernatant
was transferred to 2 mL Eppendorf tubes and RNA was extracted using the Qiagen RNeasy kit
and an automated QIAcube robotic workstation (Qiagen) according to the manufacturer’s
instructions. RNA concentration was determined using a NanoDrop ND-1000 spectropho-
tometer (NanoDrop Technologies Inc.). Nucleic acid purity was determined based on the ratio
of absorbance at 260 nm to 280 nm (A260/A280 of 1.8–2.2 was considered acceptable), and
the absence of genomic DNA contamination was determined by visualization on an agarose
gel stained by SYBR Green nucleic acid gel stain (ThermoFisher Scientific). RNA was reverse
transcribed, at a concentration of 1 μg of RNA per 20 μL reaction, using Superscript VILO
cDNA synthesis kit (Invitrogen) according to the manufacturer’s instructions.
Rat and human neural progenitor cells. NPC were lysed after 3 days of proliferation or
after 3 or 5 days of differentiation. RNA was extracted using RNeasy Mini Kit (Qiagen) accord-
ing to the manufacturer’s instructions. The maximal volume of NPC sphere RNA was tran-
scribed into cDNA using the QuantiTect Reverse Transcription Kit (Qiagen).
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Human brain. Human brain total RNA sample was purchased from Clontech (pooled
male/female, GW 20–33, catalog #636526) and stored at -80 ˚C. From every sample, 500 ng
RNA were transcribed into cDNA using the QuantiTect Reverse Transcription Kit (Qiagen).
Generation of PCR standards
Rat cortical cell cultures, rat cortical tissues, and zebrafish. PCR standards for each
gene of interest (GOI) were generated by amplifying cDNA from the rCCC, rat cortical tissues,
or zebrafish embryos using Promega GoTaq Flexi (Promega) according to the manufacturer’s
instructions. Amplified cDNA (100 μL) from pooled samples was purified using the QIAquick
PCR purification kit (Qiagen) and products were eluted in 50 μL Ultrapure Water. The DNA
concentrations were estimated using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies Inc.) and used to calculate the number of cDNA molecules/μL. Stock solutions
of 1.5 x 108 molecules/μL were generated and stored at -20 ˚C.
Rat and human neural progenitor cells. PCR standards for each GOI were generated
from six pooled PCR reaction tubes after performing the RT-PCR (= 90 μL pooled samples).
The pooled samples were purified with QIAquick PCR purification kit (Qiagen) and products
were eluted with 50 μL EB buffer (included in the kit). The DNA concentration was measured
using the NanoQuant plate device in the Tecan infinite M200 Pro reader, and the number of
cDNA molecules/μL was calculated. Stock solutions of 1.5 x 108 molecules/μL were generated
and stored at -20 ˚C.
Quantitative real time PCR (qRT-PCR) using copy number standards
Rat cortical cell cultures, rat cortical tissues, and zebrafish. Stock solutions of PCR stan-
dards for each GOI in each model were used to generate standard curves ranging from 1.5 x
102 molecules/μL to 1.5 x 107 molecules/μL. qRT-PCR was performed on a laser 7900 HT
FAST platform (Applied Biosystems, Foster City, CA, USA). Standard curves were run in par-
allel with cDNA samples with unknown transcript concentrations from rCCC, rat cortical tis-
sues, and zebrafish. Samples were run in a 384-well format with 12 μL of PCR mix per well.
PCR mix consisted of 6 μL 2X SYBR Green Power Master Mix (Life Technologies) containing
a hot start polymerase that avoids primer dimer and unspecific product formation, 0.25 μL of
10 mM stock forward primer (200 nM final concentration), 0.25 μL of 10 mM stock reverse
primer (200 nM final concentration), 1 μL cDNA (~50 ng/reaction), and 4.5 μL UltraPure
water. The PCR amplification protocol was as follows: 50 ˚C for 2 min, 95 ˚C for 10 min, and
40 cycles of 95 ˚C for 15 s, 60 ˚C for 30 s, and 72 ˚C for 30 s. Each sample was run in triplicate.
The cycle threshold (Ct) values obtained for each sample of the standard curves were used to
calculate the copy number/μL of each GOI for all unknown target samples. The expression lev-
els (as copy number/μL) were normalized to the expression of a reference gene, and the data
are presented as the mean copy number/10,000 reference gene (ppia or pgk1 for rCCC, ppia
for rat cortical tissue and β-actin for zebrafish) of three biological replicates. A target gene was
considered to be quantifiable if the ratio of the copy number target gene to the copy number
for β-actin × 1,000 exceeded 0.001. This method allows comparison of expression levels and
developmental patterns of transcript expression across models of different species. All primers
used are presented in S1 Table in the supplementary materials.
Rat and human neural progenitor cells/Human brain total RNA samples. Stock solu-
tions of PCR standards for each GOI for each model were used to generate standard curves
ranging from 1.5 x 102 molecules/μL to 1.5 x 107 molecules/μL. qRT-PCR was performed
using the Rotor-Gene Q instrumentation (Qiagen). Standard curves were run in parallel with
cDNA samples with unknown transcript concentrations from rat and human neurosphere
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cultures. The PCR mix consisted of 7.5 μL of PCR Master Mix SYBR FAST (Qiagen) contain-
ing a hot start polymerase that avoids primer dimer and unspecific product formation, 2.5 μL
solutions of each primer (stock concentration 4 μM) and 2.5 μL of cDNA (1:2.5 diluted). Sam-
ples were initially incubated for 7 min at 95 ˚C to activate the DNA polymerase. The condi-
tions for PCR amplifications were 47 cycles of 10 s at 95 ˚C for denaturation, 35 s at 60 ˚C for
primer annealing, elongation and fluorescence detection. The cycle threshold (Ct) values
obtained for each sample of the standard curves were used to calculate the copy number/μL of
each GOI for all unknown target samples. The expression levels (as copy number/μL) were
normalized to the expression of the reference gene β-actin. The data are presented as the mean
copy number/10,000 β-actin of three biological replicates. All primers used are presented in S1
Table in the supplementary materials.
Real time PCR (RT-PCR) using ddCT evaluation
Primer efficiencies were calculated from the slope of the standard curves using the following
equation:
PAE ¼ 10 
1
slope   1 ð1Þ
This calculation determines the percentile amplification efficiency (PAE), which is between 0
and 1 [30]. The CT values for GOI and reference genes were corrected by multiplying them by
their calculated PAE. PAEs for primer pairs used in experiments with human NPC were
between 0.917 (hHR) and 1.116 (hTHRa1), in experiments with rat NPC between 0.857 (rlat2)
and 1.069 (rthra1) and for primer pairs used in experiments with zebrafish were between 0.86
(thrαa) and 1.10 (lat1). From the PEAs, dCT was calculated for each sample by subtracting the
corrected CT value of the reference gene from the one of the GOI. The ddCT values were
determined by subtracting the dCT mean of the pooled proliferation/earliest time-point/sol-
vent control samples of all three independent experiments from the dCT value of each sample.
2-ddCT was calculated for each sample. 2-ddCT values were pooled for each experimental group
and the SEM was calculated. All sample and standard curve CT values as well as standard
curve equations are provided in the supporting information file S1 Appendix.
Statistical analysis
Statistical analyses were performed with GraphPad Prism 6. Transcript levels of TH signaling
components and TH-responsive genes were compared as copy numbers/10,000 reference gene
between in vitro samples and the respective in vivo brain samples and as ddCT between PND
0–1 and PND 7 rat cortex using unpaired student’s t-test with Welsh’s correction not assuming
equal SDs. P<0.05 was considered as significant. Comparisons of mRNA levels across three
different conditions (proliferating or 3 or 5 days differentiating NPC; three different time-
points for rCCC, zebrafish; TH treatments with increasing concentrations) were evaluated as
ddCT and compared to proliferating neurospheres, the earliest time-point (rCCC, zebrafish)
or the vehicle controls using one-way ANOVA with Bonferroni’s multiple comparison test.
P<0.05 was considered significant.
Results
The ontogenetic profile of transcripts encoding TH transporters, deiodinases, TH receptors,
and TH-responsive genes was determined for three in vitro models of neurodevelopment–
human neurospheres (hNPC), rat neurospheres (rNPC), and rat cortical cell cultures (rCCC)–
and in the corresponding in vivo models from which these cultures were derived, e.g., human
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brain (hbrain), rat brain (rbrain), and rat neocortex, respectively. The same transcripts were
also evaluated in embryonic/larval zebrafish (Fig 2). Multiple time points were selected for
transcriptomic analyses within each model to cover different stages of neurodevelopment (Fig
3). The hNPC and rNPC models mimic the neurodevelopmental processes of proliferation,
migration, and fate decision—neurogenesis and gliogenesis. Primary rCCC dissociated from
pooled neocortices of male and female rat pups at PND 1 were used to examine transcript
expression during neuronal polarization, axon outgrowth, dendritic arborization and synapto-
genesis. These processes are present in vitro, yet in a simplified manner compared to in vivo.
Transcripts were quantified in zebrafish at 18, 24, 72, and 120 hours post fertilization (hpf),
which encompasses both early neurodevelopmental stages, such as neural proliferation and
neural migration (18 hpf) and later stages of neurodevelopment such as synaptogenesis and
the development of mature myelinated neuronal networks (120 hpf). In larval zebrafish, the
CNS is a predominant region of early expression of TH signaling genes; however, it is impor-
tant to note that whole zebrafish larvae were analyzed in these experiments thus changes in
gene expression incorporate changes within the whole larvae. To compare expression levels
and developmental patterns of transcript expression across these models, the absolute gene
copy number of each gene was determined in proliferating NPC and at the earliest time point
investigated in rCCC and zebrafish embryos. These values were compared to copy numbers of
each target gene in the corresponding in vivo model. In NPC models, the relative expression of
each gene in differentiating cultures was compared to its expression in proliferating NPC, and
in rCCC and zebrafish, the relative expression over time was determined using the ddCT
method to compare expression at later time points to the earliest time point investigated in the
model. The mean ± SE values for the copy number and ddCT data presented as bar graphs in
Figs 4–7 are provided in S2 and S3 Tables in the supporting information.
TH transporters
The absolute copy numbers of mRNA encoding the TH transporters L-type amino acid trans-
porter 1 (LAT1; SLC7A5), LAT2 (SLC7A8), monocarboxylate transporter 8 (MCT8; SLC16A2),
and organic anion transporter 1C1 (OATP1C1; SLCO1C1) were determined at the earliest
developmental time examined in each model system (Fig 4A, 4C, 4E and 4G) and used as the
reference point for determining relative changes in transcript levels as development proceeded
(Fig 4B, 4D, 4F and 4H). Transcript for LAT1 was expressed in all the models investigated, but
at differing levels with expression of Lat1 in the rat model one to two orders of magnitude
higher than LAT1 in human and lat1 in the zebrafish models. While expression of LAT1 in
hNPC was significantly lower than in human brain (hbrain), and expression of Lat1 in rCCC
at DIV 2 was significantly higher than in rat cortical tissues at PND 1, the absolute copy num-
bers for LAT1/Lat1 differed by less than one order of magnitude between the in vitro models
and the in vivo tissues from which they were derived (Fig 4A, S2 Table). The relative expres-
sion of LAT1/Lat1 over time did not change in the human and rat models; however, in the zeb-
rafish model, lat1 expression increased as development proceeded (Fig 4B).
Transcripts encoding LAT2 were expressed at similar levels in all in vitro models with the
exception of proliferating hNPC, which had a very low copy number of LAT2. Lat2 expression
in the rat in vitro models (rNPC and rCCC) was similar to that observed in the corresponding
in vivo tissues, while the copy number of LAT2 in hNPC was more than two orders of magni-
tude lower than in hbrain (Fig 4C). However, lat2 expression in zebrafish at 18 hpf was similar
to LAT2 levels in hbrain. Relative expression of LAT2/Lat2 increased with increasing develop-
mental age in hNPC, rNPC and rCCC, while no changes in Lat2/Lat2 expression were
observed in rat cortical tissues or zebrafish (Fig 4D).
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Fig 3. Timing of key neurodevelopmental processes in human, rat, and zebrafish in comparison to the human and rat in vitro models of neurodevelopment used
to compare developmental expression profile of genes encoding TH signaling molecules. The approximate onset and duration of major neurodevelopmental
processes are depicted for each of the in vivo and in vitro models of neurodevelopment included in the transcriptional profiling of TH signaling genes. In the human, 40
weeks of gestation corresponded to 22 embryonic days and 22 postnatal days in the rat, and 120 hours post fertilization (5 days) in the zebrafish. The developmental time
line for the in vitro models branch from in vivo time scales at the point when tissue was harvested for in vitro cultures; however, the subsequent timeline of
neurodevelopment differs between in vitro models. Yellow stars indicate the time points when gene expression was analyzed. [20,31–37].
https://doi.org/10.1371/journal.pone.0221230.g003
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Fig 4. Expression of mRNA encoding thyroid hormone transporters in models of neurodevelopment. Copy numbers of transcripts
encoding LAT1 (A), LAT2 (C), MCT8 (E) and OATP1c1 (G) were determined by quantitative real time (qRT-PCR) in proliferating
hNPC and rNPC, whole brain samples from human (gestational week 20–33) and rat (postnatal day, PND 1), rCCC at DIV 2, rat cortical
tissue (PND 1), and zebrafish (18 hpf). Data are presented as copy numbers per 10,000 copies of reference gene. Reference genes used in
these studies were: (1) β-actin for hNPC, rNPC, human brain, rat brain, and zebrafish; and (2) ppia for rCCC and rat cortical tissue. The
change in expression over time of genes encoding LAT1 (B), LAT2 (D), MCT8 (F) and OATP1c1 (H) in hNPC, rNPC, rCCC, rat cortical
tissue, and zebrafish represented as the fold-change from the earliest time point investigated in each model as determined using the
ddCT method. Data are presented as the mean + SE (n = 3 biological replicates). In graphs showing copy number, � indicates significant
difference between the in vitro model and its corresponding in vivo sample at p<0.05 as determined by student’s t-test. In graphs
showing ddCT, � indicates significant difference relative to earliest time point investigated in the model at p<0.05 as determined by one-
way ANOVA with Bonferroni multiple comparison test, with the exception of data for rat cortical tissues, which consisted of only two
time points and, thus, was analyzed using student’s t-test.
https://doi.org/10.1371/journal.pone.0221230.g004
Fig 5. Expression of mRNA encoding deiodinases in models of neurodevelopment. Copy numbers of transcripts for Dio2 (A) and Dio3 (C) were determined by
quantitative real time (qRT-PCR) for proliferating hNPC and rNPC, whole brain tissue from human (gestational week 20–33) and rat (PND 1), rCCC at DIV 2, rat
cortical tissue (PND 1), and zebrafish (18 hpf). Data are presented as copy numbers per 10,000 copies of reference gene. Reference genes used in these studies were: (1)
β-actin for hNPC, rNPC, human brain, rat brain, and zebrafish; and (2) ppia for rCCC and rat cortical tissue. The change in expression over time of Dio2 (B) and Dio3
(D) is shown for hNPC, rNPC, rCCC, rat cortical tissue, and zebrafish as the fold-change from the earliest time point investigated in each model as determined using the
ddCT method. Data are presented as the mean + SE (n = 3 biological replicates). In graphs showing copy number, � indicates significant difference between the in vitro
model vs. the corresponding in vivo model at p<0.05 as determined by student’s t-test. In graphs showing ddCT, � indicates significant difference relative to the earliest
time point investigated in each model at p<0.05 as determined by one-way ANOVA with Bonferroni multiple comparison test, with the exception of data from rat
cortical tissue, which consisted of only two time points and, thus, was analyzed using student’s t-test.
https://doi.org/10.1371/journal.pone.0221230.g005
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The TH transporter MCT8 was expressed at the mRNA level in all models, with rNPC and
rbrain exhibiting the highest copy numbers, followed by hNPC and hbrain and then rCCC
and rat cortical tissues (Fig 4E). At 18 hpf, the zebrafish expressed mct8 at levels that were one
to two orders of magnitude lower than in human and rat models. Comparing in vitro models
to corresponding in vivo models, MCT8/Mct8 expression was similar; however, there was a
small but significantly higher expression of Mct8 in rCCC relative to rat cortical tissues (Fig
4E). The expression of MCT8 did not change in hNPC over time; in contrast, expression of
mct8 in the zebrafish increased significantly, while Mct8 in rNPC and rCCC decreased signifi-
cantly during development (Fig 4F).
Transcripts encoding OATP1C1 were detected in all models, with the highest level of
expression observed in the rbrain, and the lowest, in zebrafish (Fig 4G). Among the three in
vitro models, rCCC had the highest expression, which was more than an order of magnitude
higher than rNPC; whereas hNPC expression of OATP1C1 was between that observed in the
two in vitro rat models. Comparison of transcript levels for OATP1C1/ Oatp1c1 in in vitro
models versus the corresponding in vivo tissues indicated no significant differences between
rCCC and rat cortical tissues, significantly higher expression in hNPC vs. hbrain, and signifi-
cantly lower expression in rNPC vs. rbrain (Fig 4G). Ontogenetic profiling revealed that
mRNA levels of this transporter increased with time in hNPC, rat cortical tissues and zebrafish
embryos, but were downregulated with time in rNPC and rCCC (Fig 4H).
TH deiodinases
Next, we studied expression of the TH deiodinases at the mRNA level (Fig 5). Transcript
encoding iodothyronine deiodinase type 2 (DIO2) was detected in all models, but in proliferat-
ing hNPC, hbrain, and zebrafish at 18 hpf, expression was below 1 copy/ 10000 reference gene,
which was two to three orders of magnitude lower than levels observed in all rat models (Fig
5A). Expression of Dio2 was similar between rCCC and rat cortical tissues; however, Dio2
expression was significantly higher in rNPC relative to rbrain. Dio2 expression was downregu-
lated in rNPC as development proceeded, but transcription of DIO2/Dio2/dio2 increased with
time in hNPC, rCCC, rat cortical tissues, and zebrafish (Fig 5B). Transcripts encoding
iodothyronine deiodinase type 3 (DIO3) were also present in all models (Fig 5C). The highest
expression was observed in the rat in vivo models, rCCC, and zebrafish, which were each one
or more orders of magnitude higher than expression in hNPC and rNPC. Zebrafish express
two transcript variants of the dio3 gene, dio3a and dio3b, both of which were expressed at simi-
lar levels. Transcript levels for DIO3/Dio3 were lower in in vitro models relative to their corre-
sponding in vivo model, but the most profound difference in copy number was observed
between rNPC and rbrain (Fig 5C). Expression of mRNA for DIO3/Dio3/dio3 over time did
not change significantly in hNPC or rCCC, decreased significantly in rat cortical tissues, and
increased significantly in rNPC and zebrafish (Fig 5D).
Fig 6. Expression of mRNA encoding specific thyroid hormone receptor (THR) subunits and nuclear corepressor 1 (NCOR1) in
models of neurodevelopment. Copy numbers of THRα1/Thrα1/thrαa/thrab (A), THRα2/Thrα2 (C), THRβ/Thrβ/thrβ (E), and NCOR1/
Ncor1/ncor1 (G) mRNA were determined by quantitative real time (qRT-PCR) for proliferating hNPC and rNPC, whole brain tissue from
human (gestational week 20–33) and rat (PND 1), rCCC at DIV 2, rat cortical tissue (PND 1), and zebrafish (18 hpf). Data are presented as
copy numbers per 10,000 copies of reference gene. Reference genes used in these studies were: (1) β-actin for hNPC, rNPC, human brain,
rat brain, and zebrafish; and (2) ppia for rCCC and rat cortical tissue. The change in gene expression over time of transcripts encoding
THRα1 (B), THRα2 (D), THRβ (F) and NCOR1 (H) is shown for hNPC, rNPC, rCCC, rat cortical tissue, and zebrafish as the fold-change
from the earliest time point investigated in each model, as determined using the ddCT method. Data are presented as the mean + SE (n = 3
biological replicates). In graphs showing copy number, � indicates significant difference between in vitro models and their corresponding
in vivo models at p<0.05 as determined by student’s t-test. In graphs showing ddCT, � indicates significant difference relative to earliest
time point investigated in each model at p<0.05 as determined by one-way ANOVA with Bonferroni multiple comparison test, with the
exception of data from rat cortical tissue, which consisted of only two time points and, thus, was analyzed using student’s t-test.
https://doi.org/10.1371/journal.pone.0221230.g006
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Fig 7. Expression of mRNA encoding TH-responsive genes in models of neurodevelopment. Copy numbers of mRNA encoding KLF9 (A), MBP/MOBP (C), and HR
(E) were determined by quantitative real time (qRT-PCR) for proliferating hNPC and rNPC, whole brain tissue from human (gestational week 20–33) and rat (PND 1),
rCCC at DIV 2, rat cortical tissue (PND 1), and zebrafish (18 hpf). Data are presented as copy numbers per 10,000 copies of reference gene. Reference genes used in
these studies were: (1) β-actin for hNPC, rNPC, human brain, rat brain, and zebrafish; and (2) ppia for rCCC and rat cortical tissue. The change in gene expression over
time of KLF9/Klf9/klf9 (B), MBP/Mobp/mbpa (D), and HR/Hr/hr (F) is shown for hNPC, rNPC, rCCC, rat cortical tissue, and zebrafish as the fold-change from the
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TH receptors and NCOR1
Fig 6 depicts mRNA copy numbers (Fig 6A, 6C, 6E and 6G) and changes in transcript expres-
sion over time (Fig 6B, 6D, 6F and 6H) of the thyroid hormone receptor (THR) isoform
THRα1 (represented by thrαa and thrαb in zebrafish), THRα2 (for which no corresponding
transcript has been described in zebrafish), and THRβ, as well as the nuclear co-repressor
(NCOR1). The gene encoding the TR receptor isoform α1, THRa1/Thra1/thraa/thrab, was
expressed in all in vitro models, although at differing levels, with the highest copy numbers
observed in rCCC, followed by hNPC, and then rNPC. Zebrafish expressed the lowest copy
numbers, with copy numbers of both thrαa and thrαb almost three orders of magnitude lower
than was observed for Thrα1 in rCCC. Comparing THRα1/Thra1 expression in the in vitro
models to that of corresponding in vivo tissues, hNPC and rNPC were both significantly lower
than hbrain and rbrain, respectively, while the rCCC had aslightly higher expression than rat
cortical tissues (Fig 6A). Analysis of the ontogenetic profile revealed increased expression of
Thrα1 in differentiating rNPC and thrαa/thrαb in zebrafish with development (Fig 6B). In
contrast, THRα1 in hNPC and Thrα1 in rCCC and rat cortical tissue did not change signifi-
cantly over time (Fig 6B).
The mRNA copy number of Thra2 in rCCC was almost two orders of magnitude higher
than THRα2 in hNPC or Thrα2 in rNPC (Fig 6C). Expression in hNPC and rNPC was signifi-
cantly lower than that observed in their corresponding in vivo sources (Fig 6C). Analysis of the
ontogenetic expression of Thra2 revealed increasing expression in differentiating rNPC and
rCCC; in contrast, there was no change in relative expression of THRα2 in hNPC or Thra2 in
rat cortical tissue during development (Fig 6D).
The gene encoding the TR receptor β, THRβ, was detected in all the models investigated
with copy numbers in rCCC one order of magnitude higher than in hNPC and rNPC, which
were of the same order of magnitude (Fig 6E). Copy numbers of thrβ in zebrafish at 18 hpf
were between THRβ/Thrβ of rCCC and the NPC models (Fig 6E). THRβ expression in hNPC
was an order of magnitude lower than in hbrain; in contrast, less pronounced differences were
observed between the in vitro rat models (rNPC and rCCC) and their in vivo counterparts (Fig
6E). Expression of Thrβ in rCCC increased over time, mirroring a similar increase in rat corti-
cal tissues (Fig 6F). In contrast, expression of THRβ in hNPC, Thrβ in rNPC, and thrβ in zeb-
rafish did not change over the course of development (Fig 6F).
Transcript encoding NCOR1 was detected in all models investigated (Fig 6G). The highest
copy number was observed in hNPC, with lower but similar levels observed in rNPC, rCCC
and zebrafish (Fig 6G). While levels of Ncor1 were significantly lower in rNPC relative to
rbrain, across all models, expression levels in the in vitro models were of the same order of
magnitude as expression levels in their in vivo counterparts (Fig 6G). The only difference in
expression with development that was observed was a down-regulation of Ncor1 in differenti-
ating rNPC (Fig 6H).
TH-regulated neurodevelopmental genes
The genes kruppel-like factor 9 (KLF9), myelin basic protein (MBP), myelin-associated oligoden-
drocyte basic protein (MOBP), and hairless (HR) are TH-regulated genes important in
earliest time point investigated in each model, as determined using the ddCT method. Data are presented as the mean + SE (n = 3 biological replicates). In graphs
showing copy number, � indicates significant difference between the in vitro model and the corresponding in vivo model at p<0.05 as determined by student’s t-test. In
graphs showing ddCT, � indicates significant difference relative to the earliest time point investigated in each model at p<0.05 as determined by one-way ANOVA with
Bonferroni multiple comparison test, with the exception of data from the rat cortex, which consisted of only two time points and, thus, was analyzed using student’s t-
test.
https://doi.org/10.1371/journal.pone.0221230.g007
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neurodevelopment [38–41]. Fig 7 depicts the mRNA expression of these genes as absolute
copy numbers (Fig 7A, 7C, 7E and 7G) at the earliest time point investigated in each model,
and as the fold-change at later developmental times (Fig 7B, 7D, 7F and 7H).
Transcripts encoding KLF9 were detected in all the models investigated. The highest copy
number was observed in rNPC, with one order of magnitude lower copy numbers observed in
hNPC, rCCC and zebrafish (Fig 7A). Comparing the in vitro models to their in vivo counter-
parts, copy numbers of KLF9 were significantly lower in hNPC than in hbrain, while copy
numbers of Klf9 in rNPC and rCCC were significantly higher than in rbrain and rat cortical
tissues, respectively (Fig 7A). Expression of KLF9 over time was unchanged in hNPC, Klf9 was
downregulated in rNPC but upregulated in rCCC and rat cortical tissues, and klf9 was upregu-
lated in zebrafish (Fig 7B).
To assess myelin-associated genes, MBP was quantified in human models, Mobp in rat
models, and the zebrafish homolog mbpa in zebrafish. MBP/Mobp/mbpa was detected in all
models, with the highest copy number observed in hbrain, which was approximately three
orders of magnitude higher than the copy number measured in hNPC (Fig 7C). In contrast,
copy number of Mobp in rbrain was significantly lower than rNPC. Expression of Mobp in
rCCC and rat cortical tissue were both relatively low and were not significantly different from
each other (Fig 7C). While mbpa was detected in zebrafish at 18 hpf, the copy number was rela-
tively low. The expression of these myelin-associated genes increased with development in all
the models; however, only the increased expression of Mobp in rNPC and of mbpa in zebrafish
were statistically significant (Fig 7D).
The gene encoding hairless (HR) was evaluated in human and rat models, but not in zebra-
fish due to inability to identify an hr homolog in zebrafish. The mRNA copy numbers were
highest in rCCC and rat cortical tissue, with rCCC only slightly higher than rat cortical tissue
(Fig 7E). Expression of HR in hNPC and Hr in rNPC was several orders of magnitude lower
than in rCCC. Expression of HR in hNPC was lower than in hbrain, but this difference was not
statistically significant; no difference was observed in expression of Hr between rNPC and
rbrain (Fig 7E). Evaluation of the ontogenetic expression revealed only one model with a sig-
nificant change over time: Hr expression was upregulated with development in rat cortical tis-
sues (Fig 7F).
Induction of DIO3/Dio3/dio3 by exogenous TH
To determine whether there were species- or developmental stage-dependent differences in
regulation of TH-dependent genes, induction of mRNA encoding DIO3 was examined in
hNPC, rNPC, rCCC and zebrafish exposed to varying concentrations of T4 and T3 (Fig 8). T4
(30 nM) and T3 (3 nM) significantly upregulated DIO3 and Dio3 in proliferating and differen-
tiating hNPC (Fig 7A and 7B) and rNPC (Fig 8C and 8D), respectively, by two to three orders
of magnitude. Neither T4 nor T3 induced Dio3 expression in rCCC (Fig 8E and 8F). T4 (100
nM) and T3 (100 nM) upregulated dio3b in zebrafish (Fig 8G and 8H), although the induction
(a maximum of one order of magnitude increase) was less robust than that observed in the
NPC models.
Discussion
Observations from experimental models suggest that TH regulates multiple neurodevelop-
mental processes, including neurogenesis, dendritic and/or axonal growth, and myelination
[16]. Consistent with these preclinical observations, patients with TH deficiency in the CNS
due to mutations in the TH transporter MCT8 (Alan-Herndon-Dudley-Syndrome, AHDS)
exhibit delayed cortical and cerebellar development and myelination, loss of parvalbumin
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Fig 8. Induction of mRNA encoding Dio3 by exogenous T4 and T3. Transcript levels of DIO3/Dio3/dio3 following treatment with exogenous T4 or T3
were determined by quantitative real time PCR (qRT-PCR) in hNPC (A-B), rNPC (C-D), rCCC (E-F), and zebrafish (G-H) at different developmental time
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expression, abnormal calbindin-D28k content and impaired axonal maturation [42–45]. How-
ever, critical windows of TH action on specific developmental processes, and mechanisms by
which TH disruption interferes with neurodevelopment are not well characterized, and suit-
able cell models for studying these interactions are largely lacking. As an example, retinoic
acid-induced development of NT-2 cells, a common in vitro model for studying neuronal
development, is not affected by TH despite the fact that this neuronal cell line expresses func-
tional TH transporters [46].
While primary cell cultures are thought to more closely model the in vivo situation than cell
lines, it would be naïve to expect a one-to-one correlation in either the profile or absolute level
of transcripts encoding TH signaling molecules between the in vitro models and in vivo tissue
sources because the in vitro models used in this study do not recapitulate the cellular complex-
ity of the in vivo situation. For example, NPC used in this study consist of one nestin and sox-2
double positive cell type [47], which is only a fraction of cell types in the developing fetal brain
[48]. Similarly, rCCC are limited in their cell type composition compared to rodent postnatal
brains in vivo. One common difference between our in vitro models and the corresponding in
vivo tissue is the lack of vascular cell types and microglia in the former. The simpler cell com-
position in vitro vs. in vivo is important because of the known cell type and brain region speci-
ficity of TH signaling [49]. Nonetheless, we sought to determine how closely our in vitro
systems resembled their in vivo counterparts, by comparing mRNA of target genes in our in
vitro models to the tissues from which our cultures were derived. In addition, we compared
gene transcription across species, presenting these data as gene copy numbers generated using
product-specific copy number standards to enable valid cross-species evaluations, as previ-
ously described [50]. Because the samples were prepared in two different labs with slightly dis-
similar protocols, a factor of uncertainty in comparability of the respective gene copy numbers
is possibly introduced into the study. However, each of the labs prepared RNA from rat whole
brains or brain cortex, respectively. Gene copy numbers for most genes studied were in similar
orders of magnitude for both labs, except for TR, which are higher expressed in cortex than in
most other brain regions in vivo (Dowling et al. J Neurosci 2000). This comparison hints to a
fairly reasonable resemblance of qPCR results between the two labs.
Across the different species–human, rat, and zebrafish–and the different brain regions–rat
whole brain or cerebral cortex–the genes encoding TH transporters LAT1, LAT2, MCT8 and
OATP1C1 are generally expressed, indicating that at least some cell types present in the in vitro
cultures have the ability to transport TH across their membranes. Compared to the mamma-
lian systems, zebrafish expression of TH transporters is very low. This low TH transporter
expression, however, does not seem to limit the zebrafish larvae’s response to TH. In contrast
to rat CCC, which have a much higher TH transporter expression than zebrafish larvae, TH-
induced dio3 expression [51,52] is much more robust in zebrafish than in rat CCC. Also, TH
transporter expression and TH-dependent DIO3/Dio3 induction do not correlate between rat
and human NPC, indicating that transporter expression is not the limiting factor for TH gene
induction in these models. In general, there are differences in TH transporter expression
between in vitro and in vivo models. These differences may reflect the more limited profile of
cell types in vitro, which lack, for example, microvasculature that expresses MCT8/10,
OATP1C1 and LAT1/2 [17,53,54] during intrauterine development [16,46,53,55,56]. Also of
interest, Mct8 expression is much lower (~ 40-fold less) in the rat cortex than the rat whole
points. Reference genes used in these studies were β-actin (A-D, G-H) and ppia (E-F). Data are presented as the fold-change from vehicle control at the same
developmental time point, as determined using the ddCT method. (A-D, G-F) Data are shown as the mean + SE (n = 3 biological replicates); � indicates a
significant difference at p<0.05 from the time-matched vehicle control as determined by ANOVA with Bonferroni multiple comparison test. (E-F) Data are
shown as the mean + range (n = 2 biological replicates); no statistical evaluation was performed.
https://doi.org/10.1371/journal.pone.0221230.g008
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brain, which is consistent with the approximate 10-fold higher expression of Mct8 in rNPC
compared to rat CCC. TH transporter expression changes during in vitro culture of mamma-
lian cells, reflecting changes in cell differentiation and maturation. Interestingly, zebrafish lar-
vae display a TH transporter induction profile over time that differs from that of the
mammalian systems. The reasons and consequences for this species difference are currently
enigmatic.
After uptake of circulating T4 in blood by TH transporters expressed on developing brain
cells, T4 is converted by DIO2 to the higher TR affinity ligand T3 [26]. Conversely, the TH-
inactivating DIO3 metabolizes T4 to reverse T3 and T3 to T2 [57]. Both enzymes are expressed
at higher levels in in vivo rat compared to human brain, and this difference is maintained in
the in vitro systems of the respective species. Human NPC display lower DIO3 expression than
human brains, which can be explained by previously published cell type-specific brain expres-
sion in neurons [58]. Treatment of NPC cultures with TH, however, strongly induces DIO3/
Dio3 expression in differentiated human and rat NPC by 100- and 500-fold, respectively, while
Dio3 expression is not induced by T3 or T4 in rCCC. Why rCCC do not up-regulate Dio3 in
response to TH is not known as similar cortical cell cultures derived from mouse respond with
a 4-fold increase in Dio3 gene expression upon treatment of 10-day-old cultures with 1 nM T3
for 24 h [52]. In contrast, DIO2/Dio2 was expressed at much higher levels in rat compared to
human NPC. Although rat Dio2 was reported to be mainly expressed in astroglial cells in cor-
tex, hippocampus and cerebellum and in hypothalamic tanocytes of PND 15 neonatal rat brain
[59], specific expression in rat NPC had so far not been studied. Assuming a conservation of
signaling pathways when cells are transferred from in vivo to in vitro, there might be a species
difference in DIO2/Dio2 expression in human vs. rat NPC. Interestingly, dio2 expression in
zebrafish larvae is similar to the expression of this gene in human whole brains. Very low
expression of dio2 in zebrafish larvae was reported earlier [60].
TRs are present and functional in the developing brain [49]. The main isoform expressed in
mouse neurons and oligodendrocytes is Trα1, while Trβ is expressed more highly in astrocytes
[49,61]. Gene expression data from human and rat neurospheres and corresponding brain
samples confirm the higher abundance of TRα1/Trα1 compared to TRβ/TRβ isoforms, and
this expression increases during the differentiation of rat NPC. In contrast to human and rat,
the zebrafish TR homologues, traa and trab, are expressed at extremely low levels, and trb is
more abundant than tra isoforms. Despite the low tr expression levels in zebrafish larvae,
dio3b is robustly induced by TH. These data clearly indicate that TR-dependent gene induc-
tion by TH is not determined solely by relative expression levels of tr. Additional proteins that
are part of the TR transcription machinery can regulate TR function [33], for example, the
transcriptional co-repressor hairless [62]. Interestingly, Hr is expressed three to six orders of
magnitude higher in rCCC compared to human or rat NPC, which may explain the lack of TH
induction of Dio3 in these cells compared to the NPC models and the zebrafish.
Previously published TR target genes in brain include klf9 [63], myelin-related genes
[64,65] and hr [66]. We observed that these genes are differentially expressed and regulated
during cell differentiation and maturation in the absence of TH. Comparing the expression of
these genes in vitro to the corresponding in vivo counterpart is interesting since endogenous
TH is present in the in vivo situation. Therefore, it is not surprising that in vivo samples of
hbrain express higher copy numbers of HR and KLF9, which are considered a readout for gen-
eral cellular TR activation, than hNPC and four orders of magnitude higher copy numbers of
MBP, which is a marker of oligodendrocyte maturation. That similar patterns were not
observed in the rat models suggests that TH regulation may differ between the developing
human and rat brain. These species differences are consistent with previously reported differ-
ences in oligodendrocyte differentiation and maturation between mice and humans [65].
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In summary, the models examined in this study express multiple TH signaling components
but at differing levels. These models also respond differently to TH. The response depends not
only on the cell type, but also on the species and stage of cellular maturation. Therefore, when
studying chemicals’ interference with TH signaling in developing brain cells, it is important to
choose an appropriate model based on the research question being asked. Here, especially
Dio3 expression, but also other TH-responsive genes, such as Mbp or Hr, can be considered.
We recently used the hNPC system to develop an assay for detecting compounds that disrupt
TH signaling in oligodendrocytes [65]. Additional work is needed to understand the implica-
tions of gene expression of the TH signaling machinery and their phenotypic consequences of
chemical disruption of these transcriptomic profiles for the developing brain.
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